We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic has signed a definitive agreement to acquire precision oncology company Reveal Genomics. More...
20 Oct 2026
Image: The approach uses in-house pathology tests and streamlined access to specialists to shorten the diagnostic pathway for children with immune conditions. (Image Credit: iStock)

Streamlined Genetic Testing Speeds Pediatric Immune Disorder Diagnosis

A new in-house genetic testing model cuts diagnosis of pediatric immune disorders from 12 months to as little as two weeks. More...
20 Oct 2026
Image: The study analyzed saliva samples from people undergoing treatment for OCD (Image Credit: Adobe Stock)

Study Links Saliva-Based Epigenetic Signals to OCD Treatment Outcomes

New findings link DNA methylation markers to OCD psychotherapy response, supporting personalized treatment. More...
20 Oct 2026
Image: The newly released  RepX uses Electronic Genome Mapping (EGM) data generated on the OhmX Platform (Photo courtesy of Nabsys)

Genomic Tool Supports Analysis of Repeat Expansions Linked to Inherited Disorders

A newly launched analysis pipeline now uses electronic genome mapping data to investigate disease-associated repeat expansions More...
20 Oct 2026
Image: The definitive agreement covers Myriad Genetics’ Prenatal Health testing business, including the Prequel, Foresight, SneakPeek, and FirstGene tests. (Photo courtesy of Myriad Genetics)

Myriad Genetics to Sell Prenatal Testing Portfolio to Labcorp

Myriad Genetics has entered into a definitive agreement to sell its Prenatal Health testing business to Labcorp for $210 million. More...
20 Oct 2026
Image Credit: iStock

Managed Care Report Examines Barriers to Breast Cancer Biomarker Testing

A new analysis examines uncertainty around biomarker testing and managed care for advanced breast cancer with ESR1 mutations. More...
20 Oct 2026
Image: Acute myeloid leukemia is the first of several disease areas the collaborators plan to pursue together as part of efforts to advance precision diagnostics (Image Credit: Adobe Stock)

Immune Profiling Initiative Aims to Improve Bone Marrow Analysis in Leukemia

A new collaboration aims to develop bone marrow immune profiling tests to measure disease burden before and after treatment. More...
20 Oct 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+